Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metformin resistant MDA-MB-468 cells exhibit EMT-like phenotype and increased migration capacity.

Molecular biology reports - 1 Jul 2022

Cingir Koker Sahika, Yalcin Banu, Dogan Turacli Irem

Abstract excerpt

PURPOSE: Metformin is one of the most prescribed drugs for the treatment of type II diabetes. Its anti-proliferative effect is also taken advantage for the treatment of cancer. Despite many of the studies mentioning the positive effects of metformin in inhibiting the proliferation of cancer cells, there are also studies which questions this idea as well. METHODS: In this study, we investigated the most widely...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Cell Movement
Share to Cell Proliferation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Epithelial-Mesenchymal Transition

Share to Metformin

Share to Phenotype

Share to Phosphatidylinositol 3-Kinases

Source

Identifiers

PMID: 35355210
DOI: 10.1007/s11033-022-07381-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metformin resistant MDA-MB-468 cells exhibit EMT-like phenotype and increased migration capacity.PMID 35355210Read ↗

Metformin effects on malignant cells and healthy PBMC; the influence of metformin on the phenotype of breast cancer cells.Semantic proximity Read ↗

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem CellsSemantic proximity Read ↗

Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression patternSemantic proximity Read ↗

Metformin for the treatment of breast cancer: a scoping review of randomized clinical trialsSemantic proximity Read ↗

Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.Semantic proximity Read ↗

Metformin May Block the Way Breast Cancer Metastasis: A Meta-analysis and Mechanism ReviewSemantic proximity Read ↗

K‑ras gene mutation as a predictor of cancer cell responsiveness to metformin.Semantic proximity Read ↗

Parthenolide Inhibits Migration and Reverses the EMT Process in Breast Cancer Cells by Suppressing TGFβ and TWIST1Semantic proximity Read ↗

Effect of metformin on the proliferation, apoptosis, invasion and autophagy of ovarian cancer cellsSemantic proximity Read ↗

Involvement of EGFR in the promotion of malignant properties in multidrug resistant breast cancer cells.Semantic proximity Read ↗

Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy.Semantic proximity Read ↗

Metformin may improve the outcome of patients with breast cancer and type 2 diabetes mellitus through the effect of tumor immune microenvironment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.